Uncategorized


November 15, 2024

Trump Appointees: Our Take

By Joe Lieber

If taken individually, we would expect Tulsi Gabbard, Matt Gaetz and Robert F. Kennedy Jr. all to lose their confirmation battles and either have their names withdrawn for consideration or lose a Senate floor vote….

Read More >>

November 15, 2024

(DKNG, CZR, FLUT, MGM, PENN) Texas Sports Gaming Update

By Joe Lieber

Investors should keep an eye on whether Texas Lt. Gov. Dan Patrick (R-TX), an opponent of legalizing sports betting, is appointed to a position in the Trump administration, as some reports have speculated given his…

Read More >>

November 15, 2024

RFK to HHS: Biopharma / Lifesciences Smoke or Fire?

By John Leppard

Key Takeaways: We are initially skeptical that Trump’s selection of Robert F. Kennedy Jr. (RFK) to lead HHS can survive Senate confirmation but, if we are wrong, would note that any HHS secretary is constrained…

Read More >>

November 14, 2024

(ENSG, PACS, OHI, CTRE, SBRA) Nursing Home Relief from Minimum Staffing Rule Still Likely But as Part of FY25 Spending Bill

By Beth Steindecker

Key Takeaways:  We still expect nursing homes and their post-acute care REIT landlords to secure a reprieve from the Biden CMS rule imposing minimum nurse staffing requirements on these long-term facilities. However, we see that…

Read More >>

November 14, 2024

Macro Sequencing: Tariffs, Tax Cuts, and a Quick Take on Nominations

By Joe Lieber

Key Takeaways:   We see the ~60% China tariffs being implemented before the tax cuts are passed and likely within the first 100 days.   We believe there’s a very good chance tax cuts pass…

Read More >>

November 14, 2024

Skin Substitutes: Relief for COLOB.DC, Headiwnds for CTEC.LN & ORGO

By John Leppard

Key Takeaways: The coordinated release of finalized skin substitute local coverage determinations (LCDs) from all seven Medicare Administrative Contractors (MACs) this morning is largely in keeping with our expectations, with Coloplast (COLOB.DC) seeing the greatest…

Read More >>

November 13, 2024

EXAS, GH: Next Steps on Next Gen Test Rates

By John Leppard

Key Takeaways: Following the split market reaction to EXAS [-29%] and GH [+25%] 3Q24 earnings reports last week, and investors looking to the opportunities associated with next generation colorectal cancer (CRC) screening tests Cologuard Plus…

Read More >>

November 13, 2024

Louisiana 51% Sports Betting Tax Hike Bill Withdrawn

By Joe Lieber

In positive news for DKNG, CZR, MGM and PENN, Louisiana state Rep. Roger Wilder (R) withdrew his bill this morning that would hike taxes on sports gambling from 15% to 51%.  Yesterday, we wrote here…

Read More >>

November 12, 2024

(UNH, AMED) Reported Threat of DOJ Complaint Brings Overhang and Extended Invitation to Negotiate

By Beth Steindecker

Key Takeaways: We continue to expect that UNH’s acquisition AMED will be completed, despite reports that the DOJ is preparing to sue to block the $3.3B deal on antitrust concerns. While clearly a setback, this…

Read More >>

November 12, 2024

(DKNG, CZR, FLUT, MGM, PENN) Don’t Bet on Louisiana’s 51% Tax Hike

By Joe Lieber

We doubt that legislation introduced yesterday by State Rep. Roger Wilder (R) to increase the sports Gross Gaming Revenue (GGR) tax from 15% to 51% in Louisiana will be passed in the special session, which…

Read More >>